Josephine P. Briggs, M.D.
On February 17, President Obama signed the American Recovery and Reinvestment Act of 2009 (Recovery Act). Funds from the Recovery Act will be invested in the construction and renovation of research and educational facilities, as well as groundbreaking scientific research that will improve the health of our Nation.
We appreciate that the President and Congress have recognized both the economic and health impacts of biomedical and behavioral research.
The goals of the Recovery Act include:
- Preserving and creating jobs
- Promoting economic recovery
- Increasing economic efficiency by spurring technological advances in science and health.
The Recovery Act offers a wonderful opportunity for the biomedical research and CAM communities to participate in furthering both the mission of the NIH and the health of the economy. The impact is expected to extend beyond the immediate scientists who will receive funds, to allied health workers, technicians, students, trade workers, and others who will receive the leveraged benefits. Beyond the immediate economic stimulus, the long-term impact from the science funded by the Recovery Act will have a positive impact upon the health of the Nation for years to come.
Under the new law, NIH will receive approximately $10.4 billion for use in fiscal years 2009 and 2010—$1 billion for extramural construction, repairs, and renovation of research facilities and $8.2 billion in support of scientific research priorities.
We anticipate that NCCAM will receive approximately $31 million to be spent in the next 2 years. We expect that these funds will be used to fund new and pending grant applications that will help advance the field of CAM research and can realistically be completed in 2 years.
In addition, NCCAM is participating in the NIH-wide Challenge Grant Initiative. Challenge Grants will support research in areas that address specific scientific and health research challenges in biomedical and behavioral research that would benefit from significant 2-year jumpstart funds. NIH anticipates funding 200 or more of these grants, each of up to $1 million in total costs, pending the number and quality of applications and availability of funds. In addition, Recovery Act funds allocated to NIH specifically for comparative effectiveness research may be available to support additional grants.
While the Recovery Act is complex, we join the President’s commitment to be efficient and transparent in how the funds are used and reported. We are grateful for the opportunity to work with our NIH colleagues as well as the extramural scientific community to further the health of the Nation and jumpstart the economy.
- For more information, see NCCAM Investments Related to the American Recovery and Reinvestment Act